COSCIENS Biopharma Inc. Key Management Personnel Compensation Share-based Payment
COSCIENS Biopharma Inc. (CSCIF) reported Key Management Personnel Compensation Share-based Payment of $411.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2026-03-25
- COSCIENS Biopharma Inc. key management personnel compensation share-based payment for the quarter ending 2022-03-31 was $16.00K, a 60.00% increase year-over-year.
- COSCIENS Biopharma Inc. key management personnel compensation share-based payment for the quarter ending 2021-12-31 was $17.00K, a 0.00% change year-over-year.
- COSCIENS Biopharma Inc. key management personnel compensation share-based payment for the quarter ending 2021-09-30 was $13.00K, a 18.75% decline year-over-year.
- COSCIENS Biopharma Inc. key management personnel compensation share-based payment for the quarter ending 2021-06-30 was $255.00K.
| Period end | Key Management Personnel Compensation Share-based Payment 3 month | Key Management Personnel Compensation Share-based Payment 6 month | Key Management Personnel Compensation Share-based Payment 9 month | Key Management Personnel Compensation Share-based Payment 12 month | Key Management Personnel Compensation Share-based Payment 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $411.00K 20-F · filed 2026-03-25 | ||||
| 2023-12-31 | $121.00K 20-F · filed 2026-03-25 | $284.00K 20-F · filed 2024-03-27 | |||
| 2022-12-31 | $44.00K 20-F · filed 2025-04-09 | $460.00K 20-F · filed 2023-03-23 | |||
| 2022-03-31 | $16.00K 6-K · filed 2022-05-11 | $33.00K derived: sum of 2 quarters · filed 2024-07-17 | $46.00K derived: sum of 3 quarters · filed 2024-07-17 | $301.00K derived: sum of 4 quarters · filed 2024-07-17 | |
| 2021-12-31 | $17.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $30.00K derived: sum of 2 quarters · filed 2024-07-17 | $285.00K derived: sum of 3 quarters · filed 2024-07-17 | $295.00K 20-F/A · filed 2024-07-17 | |
| 2021-09-30 | $13.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $268.00K derived: sum of 2 quarters · filed 2021-11-04 | $278.00K 6-K · filed 2021-11-04 | $295.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-06-30 | $255.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-05 | $265.00K 6-K · filed 2021-08-05 | $282.00K derived: sum of 3 quarters · filed 2024-02-15 | $298.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-03-31 | $10.00K 6-K · filed 2022-05-11 | $27.00K derived: sum of 2 quarters · filed 2024-02-15 | $43.00K derived: sum of 3 quarters · filed 2024-02-15 | ||
| 2020-12-31 | $17.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | $33.00K derived: sum of 2 quarters · filed 2024-02-15 | $160.00K 20-F/A · filed 2024-02-15 | ||
| 2020-09-30 | $16.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $143.00K 6-K · filed 2021-11-04 | |||
| 2020-06-30 | $127.00K 6-K · filed 2021-08-05 | ||||
| 2018-12-31 | $462.00K 20-F · filed 2019-04-01 | ||||
| 2017-12-31 | $87.00K 20-F · filed 2019-04-01 | ||||
| 2016-12-31 | $1.05M 20-F · filed 2019-04-01 | ||||
| 2015-12-31 | $828.00K 20-F · filed 2018-03-28 |